Cite
MLA Citation
J. Wang et al.. “P554: GILTERITINIB VERSUS SALVAGE CHEMOTHERAPY FOR RELAPSED/REFRACTORY FLT3-MUTATED ACUTE MYELOID LEUKEMIA: A PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL TRIAL IN ASIA.” HemaSphere, vol. 6, n.d., pp. 453–454. http://access.bl.uk/ark:/81055/vdc_100159757470.0x000006